e.g. Filippa Pettersson or Cancer Res. 75(6) , 1102-12, (2015) or 10.1002/anie.201600521
GPIIb/IIIa integrin antagonists with the new conformational restriction unit, trisubstituted β-amino acid derivatives, and a substituted benzamidine structure
Ethyl N-[3-(2-fluoro-4-(thiazolidin-3-yl (imino) methyl) benzoyl) amino-2, 2- dimethylpentanoyl] piperidine-4-acetate 40 (NSL-96184) is a highly potent and orally active fibrinogen receptor antagonist, which is characterized by the presence of the trisubstituted β- amino acid residue, 3-ethyl-2, 2-dimethyl-β-alanine. This compound was developed on the basis of the SAR study of N-[3-(N-4-amidinobenzoyl) amino-2, 2-dimethyl-3- ...
[Marchand-Brynaert, Jaqueline; Moya-Portuguez, Manuel; Lesuisse, Dominique; Ghosez, Leon Journal of the Chemical Society, Chemical Communications, 1980 , # 4 p. 173 - 174]